Stock listing
Nextbiomedical Co. Ltd.
Selected listing: 389650 · KRX · KRW · KR
Nextbiomedical Co. Ltd. (KRX:389650), Health Technology. Latest release Jul 6, 2026: Nexsphere-F™ Clinical Study Published in Radiology, Showing 57% Reduction…
- Ticker
- KRX:389650
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- KRX
- Currency
- KRW
About Nextbiomedical Co. Ltd.
Nextbiomedical Co. Ltd. is a public company listed under the ticker 389650 on the Korean market. Nextbiomedical focuses on developing innovative biomedical solutions to address various health challenges.
Latest news from Nextbiomedical Co. Ltd.
Nexsphere-F™ Clinical Study Published in Radiology, Showing 57% Reduction in Knee Osteoarthritis Pain
July 6, 2026
NEXTBIOMEDICAL Announces First Patient Enrolled in U.S. FDA Pivotal Trial of Nexsphere-F™ for Knee Osteoarthritis Pain
October 13, 2025
Nextbiomedical Publishes Landmark Study in GUT Demonstrating Nexpowder™ Significantly Reduces Rebleeding After Endoscopic Hemostasis
May 29, 2025
Research Nextbiomedical Co. Ltd.
Nextbiomedical Co. Ltd. company profile
View the public company page for Nextbiomedical Co. Ltd. on 6ix.
Nextbiomedical Co. Ltd. news
Read company news and market updates connected to Nextbiomedical Co. Ltd..
Nextbiomedical Co. Ltd. investor events
Find investor webinars, events, and replay context for Nextbiomedical Co. Ltd..